Stigma
Meeting category
Date(s)
26 Mar 2022
Program Language
English
Location
Dubai, United Arab Emirates
Meeting type
Live Meeting
Organizer

Reducing Barriers to Successful HIV Care Forum 2022

Related Enduring Materials

Enduring Materials
Saturday, 26 March 2022
Session 1: Improving Treatment Success -
Update on the 95-95-95 Goals in the GCC Region
Aqeel Saleem, MD
Tawam Hospital / Abu Dhabi Healthcare Company (SEHA), United Arab Emirates
New Therapeutics: How Do They Help Us
Ghassan Wali, MD, FRCP(C)
King Faisal Specialist Hospital and Research Centre, Saudi Arabia
New Formulations / Delivery Devices
Mas Chaponda, MD, PhD, FRCP
Hamad Medical Corporation, Qatar
Session 2: Barriers of Successful HIV Prevention -
International Experiences With HIV PrEP Programs
Donn Colby, MD, MPH
U.S. Military HIV Research Program (MHRP) / Center for Applied Research on Men and Community Health, United States / Vietnam
Update on HIV PrEP Programs in the GCC Region
Nezar Bahabri, MD
Dr Samir Abbas Hospital / Saudi Society of Medical Microbiology and Infectious Diseases, Saudi Arabia
Barriers to Successful HIV Prevention - Health Care Provider Perspective
Faryal Khamis, MD
Royal Hospital, Ministry of Health, Oman
Barriers to Successful HIV Prevention - Community-Led Initiatives
Michael Meulbroek
BCN Checkpoint, Spain
Session 3: Barriers of Successful HIV Treatment -
International Experiences with U=U Message
Bruce Richman
Prevention Access Campaign, United States
Impact of the U=U Message on HIV Care - Health Care Perspective
Jameela Al-Salman, MD
Salmaniya Medical Complex, Kingdom of Bahrain
Impact of the U=U Message on HIV Care - Community Perspective
Alaa H. Alali, MD, SBIM, SFID
King Saud Medical City, Saudi Arabia
Overview
Welcome

The Reducing Barriers to Successful HIV Care Forum 2022 took place in Dubai, United Arab Emirates on 26 March 2022.

As shown by the significant and increasing reports of cities and countries achieving the 90-90-90 targets and beyond, HIV is now a treatable infection. In the past few years, there have been advances not only in the efficacy of medication but, equally importantly, in their toxicity profile and ease of administration. This has led to greater adherence overall, resulting in positive long-term results.

However, large groups of individuals either remain undiagnosed or are diagnosed but do not seek care. Indeed, undiagnosed individuals form the most significant gap in our 90-90-90 targets. For further improvements in our cascades of care, these groups must be targeted.

But why does this happen?

Undoubtedly, this issue has much to do with fear. The fear of testing, receiving a positive diagnosis, attending an HIV centre, and the subsequent discrimination that either does or is perceived to occur.

Such fears result in unnecessary morbidity and mortality, mainly due to late diagnosis, along with an increased risk of transmission within the population.

Change is coming!

We are, however, striving to make a change, and there are success stories!

Come and hear how you can challenge and be part of the solution to stigma and discrimination. Listen to stories of both success and failure from our experienced faculty.

The triumph of HIV treatment can only truly begin when we can succeed in improving testing and linkage to care. We are all beholden to take part in this challenge.

Program Director
Local Chairs
General Information 
Unique Features
- Half-Day Forum
- Keynote Lectures
- Highly Interactive
- Panel Discussion
- Audience Discussion
Practical Information 
Certificate of Attendance
A digital certificate of attendance will be sent to participants after successfully completing the forum and post-meeting survey.
Language
The official language of the forum is English.
Disclaimer
This forum is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this forum, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this forum. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the forum.
Liability and Insurance
By registering for the forum participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official forum sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the forum is finished, provided the speaker has given permission to do so.
Scholarships

Scholarship Application is now closed.

Virology Education (VE) is offering scholarships to attend the forum Reducing Barriers to Successful HIV Care. The scholarship covers registration, travel, and accommodation support.

The scholarships are supported by industry. These companies will have no control, influence, or involvement in the selection of any attendees.

The scholarship application deadline is Friday, 11 February 2022 at 23:59 GST.

What is Expected from the Scholarship Recipients?

All scholarship awardees are required to attend the full forum. Awardees must sign in at the beginning of the forum day and sign off at the end of the forum day as requested by the Forum Organizer. At the close of the forum, awardees must have completed the daily and overall forum evaluations.

Recipient will provide post-forum feedback and a summary about his/her forum experience within one month after the end of the forum. The feedback questionnaire will be an online survey with the recipient providing feedback on their experience at the forum, scholarship procedure, and how they will implement the knowledge acquired at the forum in their daily practice. The questionnaire will be sent to each recipient by email within one week after the conclusion of the forum.

What Does the Scholarship Cover?
The Scholarship covers:
- Registration fee
- Travel support
- Accommodation support
What is the Application Procedure?
The scholarship applications must be submitted online through our Scholarship Application Portal by 11 February 2022. The applicant will be asked to submit a motivational letter (max. 200 words) describing how their patients/research/community will benefit from the knowledge gained at this forum, and their knowledge dissemination strategy, a CV, and a letter of recommendation (optional).

- All applications will be acknowledged upon receipt.
- All applications will be reviewed by an independent Scholarship Review Committee.
- Successful applicants will be sent a scholarship agreement.
- After receipt of the signed scholarship agreement, successful applicants will receive instructions for logistical arrangements.
Eligibility
Applicants must:
- Be proficient in English, in order to interact with faculty and fellow attendees
- Be professionally involved in the field of HIV in the Middle Eastern Region
- Be able to show benefits to their patients / research / community from attending the forum
- Be willing and able to share information learned at the forum with a larger community

The conference organizer will automatically decline all scholarship applications that do not conform to the eligibility terms.
Selection Criteria
- Professional background
- Country of residence
- Recommendation by your supervisor
- Demonstrable benefits to patients / research / community by the knowledge to be gained at this forum
- Strategy of knowledge dissemination
- Early-Career Investigator
Scholarship Terms and Conditions
- The applicant will attend the entire forum program.
- The applicant will provide the completed post-forum feedback and summary to the Forum Organizer.
- The applicant must attend the forum and confirm that they will be responsible for all other costs associated with forum attendance such as internet usage and use of a computer device.
- The applicant will not hold the Forum Organizer liable for any losses, costs, expenses, causes of action, claims, and suits for property damage, theft of property, or personal injury (including death) arising in connection with the Scholarship and participation in the forum.
- The applicant agrees to be responsible for taking out their relevant own insurance policies.
- The Scholarship is non-transferable.
- Incomplete Scholarship applications will not be considered.
- Retrospective Scholarship applications will not be considered.
- Forum organizer cannot be held responsible for any incorrect information that is submitted through the Scholarship application portal.
- Scholarship applications will be considered until the exhaustion of funds.
- The Scholarship applicants will be notified of the decision by email. Successful applicants will be notified with further instructions.
- Forum organizer reserves the right to make the final decision regarding all Scholarship applications, which cannot be disputed.
Support
Acknowledgment

"This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity."

Endorsers
COVID-19

Health & Safety Measures regarding COVID-19

Ensuring the health and safety of our attendees, suppliers, and staff is our absolute number one priority. In order to provide a safe conference environment, all hybrid and live events organized by Virology Education will follow the national health and safety measures of the country where the meeting is being held in. We kindly ask that all attendees carefully abide by these measures to assist us in ensuring a safe environment for all.

National Health & Safety Measures

The health and safety measures that will be taken by Virology Education during the Reducing Barriers to Succesful HIV Care Forum are listed on the government website of the United Arab Emirates. Please read them very carefully before traveling to the conference venue. 

Our staff will be available onsite to address any questions or concerns that you might have. If you have any questions in advance, please contact the Conference Secretariat at magda.sevlidou@amededu.com.

Traveling to the United Arab Emirates

Virology Education strongly advises participants to check the government website of the United Arab Emirates and Dubai for the latest and most accurate information about the rules regarding travel.

Please be aware of measures such as testing requirements, vaccination requirements, whether your country of origin is mentioned on the Red List, etc. 

Access to the Conference Venue

In order to be granted access to the conference venue, the following guidelines must be observed. 

Face masks

Attendees are required to wear a face mask in order to enter the conference venue. The face mask has to be worn during the entire length of the conference. Speakers on stage may remove their masks only if they maintain 4m distance.

Social Distancing

A minimum of 2m social distancing must be maintained at all times. 

Hand Sanitizer

Multiple sanitizing stations will be set up throughout the conference venue. Please make sure to use them regularly.

What if I get ill during the event?

Should an attendee become ill or exhibit COVID-19 symptoms at any time during the event, the attendee will safely withdraw from the event venue and immediately notify the event organizer with details of other attendees which have been in close contact at the event. By registering for the event, the attendee declares, acknowledges, and accepts that they will comply with all local government requirements should they become ill or exhibit COVID-19 symptoms during the event.

Liability Waiver
Virology Education cannot guarantee that its participants, volunteers, partners, or others in attendance will not become infected with COVID-19.
To the maximum extent permitted by law, Virology Education accepts no liability for any illness, COVID-19 related or otherwise, that may subsequently be contracted after or during the event.
All participants acknowledge and agree that they are attending the event at their own risk.